These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37653613)

  • 1. Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?
    Høgdall EVS; Christensen IJ; Høgdall C
    APMIS; 2023 Oct; 131(10):536-542. PubMed ID: 37653613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishing the Danish CancerBiobank].
    Modin C; Bjerregaard B; Ørntoft T; Høgdall E;
    Ugeskr Laeger; 2010 May; 172(19):1446-50. PubMed ID: 20470655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research.
    Zelisse HS; van Gent MDJM; de Ridder S; van der Aa MA; van Altena AM; Bart J; Belien JAM; Boere IA; Bosch SL; Broeks A; Bulten J; Collée M; Groenendijk FH; Horlings HM; Jansen MPHM; Jonges TGN; Kooreman LFS; de Kroon CD; Lambrechts S; Lok CAR; Piek JM; Reyners AKL; Roes EM; Simons M; Wisman GBA; Yigit R; Zweemer RP; Mom CH; van de Vijver MJ; Dijk F;
    Gynecol Obstet Invest; 2022; 87(6):389-397. PubMed ID: 36450222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?
    Lydiksen L; Jensen-Fangel S; Blaakaer J
    Gynecol Oncol; 2014 Jun; 133(3):454-9. PubMed ID: 24726613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
    Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
    Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Registration of primary ovarian cancer in Denmark].
    Petri AL; Høgdall C; Lidegaard O
    Ugeskr Laeger; 2009 Feb; 171(6):408-11. PubMed ID: 19208328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary ovarian cancer. A comparison of registrations in the Danish Cancer Registry and the Pathology Data Bank].
    Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK;
    Ugeskr Laeger; 2007 Jan; 169(1):50-4. PubMed ID: 17217888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
    Petri AL; Kjaer SK; Christensen IJ; Blaakaer J; Hogdall E; Jeppesen U; Mosgaard BJ; Pagel JD; Stilling L; Thranov I; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(5):536-42. PubMed ID: 19308749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
    De Gregorio A; Nagel G; Möller P; Rempen A; Schlicht E; Fritz S; Flock F; Kühn T; Thiel F; Felberbaum R; Ebner F; De Gregorio N; Friedl TWP; Wiesmüller L; Kuhn P; Schmitt M; Janni W; Rothenbacher D; Huober J
    Arch Gynecol Obstet; 2020 Jan; 301(1):273-281. PubMed ID: 31781887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morocco's First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges.
    Lhousni S; Belmokhtar KY; Belmokhtar I; Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Tajir M; Charif M; Zerrouki K; Benajiba N; Rkain M; Babakhouya A; Kouismi H; Thouil A; Latrach H; Amrani R; Messaoudi S; Ayyad A; Sidqi Z; Andaloussi Serraj K; Hamaz S; Alaoui H; Bachir H; Bentata Y; Haddiya I; Choukri M; Seddik R; Bennani A; Dikhaye S; Oneib B; Elghazouani F; El Mahi O; Benzirar A; Oufkir AA; Housni B; Mimouni A; Saadi H; Belahcen M; El Harroudi T; Ouarzane M; Bellaoui M
    Biomed Res Int; 2020; 2020():8812609. PubMed ID: 33376744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
    Le Page C; Rahimi K; Köbel M; Tonin PN; Meunier L; Portelance L; Bernard M; Nelson BH; Bernardini MQ; Bartlett JMS; Bachvarov D; Gotlieb WH; Gilks B; McAlpine JN; Nachtigal MW; Piché A; Watson PH; Vanderhyden B; Huntsman DG; Provencher DM; Mes-Masson AM
    BMC Cancer; 2018 Mar; 18(1):347. PubMed ID: 29587661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Jarle Christensen I; Gayther S; Jacobs IJ; Høgdall CK
    Pathology; 2008 Aug; 40(5):487-92. PubMed ID: 18604735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
    Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian cancer--modern approach to its origin and histogenesis].
    Nowak-Markwitz E; Spaczyński M
    Ginekol Pol; 2012 Jun; 83(6):454-7. PubMed ID: 22880466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.